Non-herbal nutritional supplements for symptom relief in adjuvant breast cancer: creating a doctor-patient dialogue.
Identifieur interne : 006436 ( Ncbi/Curation ); précédent : 006435; suivant : 006437Non-herbal nutritional supplements for symptom relief in adjuvant breast cancer: creating a doctor-patient dialogue.
Auteurs : Noah Samuels [Israël] ; Elad Schiff [Israël] ; Eran Ben-Arye [Israël]Source :
- BMJ supportive & palliative care [ 2045-4368 ] ; 2014.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Antineoplastic Agents.
- adverse effects : Chemoradiotherapy, Adjuvant.
- complications : Breast Neoplasms.
- therapy : Breast Neoplasms.
- Clinical Trials as Topic, Dietary Supplements, Female, Humans, Physician-Patient Relations, Treatment Outcome.
Abstract
Patients with breast cancer frequently turn to complementary medical therapies, including non-herbal nutritional supplements (NHNS). A number of NHNS products have been shown to potentially reduce the incidence and severity of adjuvant treatment-related symptoms. We review the literature and summarise the potential beneficial effects of these products and address issues regarding the safety of this practice. We offer an evidence-based approach for advancing a dialogue between doctors and patients interested in NHNS for adjuvant treatment-related toxicities. Taxane agents such as paclitaxel are frequently complicated by peripheral sensory neuropathy. The findings from several studies suggest that supplementation with vitamin E, glutamine and acetyl-L-carnithine may reduce the incidence and severity of paclitaxel-induced neuropathy. Glutamine has also been shown to reduce the incidence and severity of chemotherapy-induced and radiation-induced oral mucositis. Selenium can reduce upper limb lymphoedema following surgery and radiation treatments, and an antioxidant supplement has exhibited a protective effect against radiation-induced dermatitis. Finally, vitamin D has been shown to be effective in reducing the incidence and severity of arthralgia resulting from treatment with the aromatase inhibitor letrozole. The use of coenzyme Q10 was not found to be of benefit for cancer-related fatigue. There is a need to develop an open and non-judgmental dialogue between doctors and their patients with breast cancer, respecting the needs of the patient while addressing issues related to the efficacy and safety of NHNS products. Referral of patients to an integrative medicine consultant may help achieve these goals.
DOI: 10.1136/bmjspcare-2013-000463
PubMed: 24644186
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001616
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001616
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001616
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :006436
Links to Exploration step
pubmed:24644186Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Non-herbal nutritional supplements for symptom relief in adjuvant breast cancer: creating a doctor-patient dialogue.</title><author><name sortKey="Samuels, Noah" sort="Samuels, Noah" uniqKey="Samuels N" first="Noah" last="Samuels">Noah Samuels</name><affiliation wicri:level="1"><nlm:affiliation>Integrative Oncology Program, The Oncology Service and Lin Medical Center, Clalit Health Services, Haifa, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Integrative Oncology Program, The Oncology Service and Lin Medical Center, Clalit Health Services, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Schiff, Elad" sort="Schiff, Elad" uniqKey="Schiff E" first="Elad" last="Schiff">Elad Schiff</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Bnai-Zion Hospital, Haifa, Israel The Department for Complementary/Integrative Medicine, Law and Ethics, The International Center for Health, Law and Ethics, Haifa University, Haifa, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Internal Medicine, Bnai-Zion Hospital, Haifa, Israel The Department for Complementary/Integrative Medicine, Law and Ethics, The International Center for Health, Law and Ethics, Haifa University, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Ben Arye, Eran" sort="Ben Arye, Eran" uniqKey="Ben Arye E" first="Eran" last="Ben-Arye">Eran Ben-Arye</name><affiliation wicri:level="1"><nlm:affiliation>Integrative Oncology Program, The Oncology Service and Lin Medical Center, Clalit Health Services, Haifa, Israel Complementary and Traditional Medicine Unit, Department of Family Medicine, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel Clalit Health Services, Haifa, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Integrative Oncology Program, The Oncology Service and Lin Medical Center, Clalit Health Services, Haifa, Israel Complementary and Traditional Medicine Unit, Department of Family Medicine, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel Clalit Health Services, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24644186</idno><idno type="pmid">24644186</idno><idno type="doi">10.1136/bmjspcare-2013-000463</idno><idno type="wicri:Area/PubMed/Corpus">001616</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001616</idno><idno type="wicri:Area/PubMed/Curation">001616</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001616</idno><idno type="wicri:Area/PubMed/Checkpoint">001616</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001616</idno><idno type="wicri:Area/Ncbi/Merge">006436</idno><idno type="wicri:Area/Ncbi/Curation">006436</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Non-herbal nutritional supplements for symptom relief in adjuvant breast cancer: creating a doctor-patient dialogue.</title><author><name sortKey="Samuels, Noah" sort="Samuels, Noah" uniqKey="Samuels N" first="Noah" last="Samuels">Noah Samuels</name><affiliation wicri:level="1"><nlm:affiliation>Integrative Oncology Program, The Oncology Service and Lin Medical Center, Clalit Health Services, Haifa, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Integrative Oncology Program, The Oncology Service and Lin Medical Center, Clalit Health Services, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Schiff, Elad" sort="Schiff, Elad" uniqKey="Schiff E" first="Elad" last="Schiff">Elad Schiff</name><affiliation wicri:level="1"><nlm:affiliation>Department of Internal Medicine, Bnai-Zion Hospital, Haifa, Israel The Department for Complementary/Integrative Medicine, Law and Ethics, The International Center for Health, Law and Ethics, Haifa University, Haifa, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Internal Medicine, Bnai-Zion Hospital, Haifa, Israel The Department for Complementary/Integrative Medicine, Law and Ethics, The International Center for Health, Law and Ethics, Haifa University, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Ben Arye, Eran" sort="Ben Arye, Eran" uniqKey="Ben Arye E" first="Eran" last="Ben-Arye">Eran Ben-Arye</name><affiliation wicri:level="1"><nlm:affiliation>Integrative Oncology Program, The Oncology Service and Lin Medical Center, Clalit Health Services, Haifa, Israel Complementary and Traditional Medicine Unit, Department of Family Medicine, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel Clalit Health Services, Haifa, Israel.</nlm:affiliation><country xml:lang="fr">Israël</country><wicri:regionArea>Integrative Oncology Program, The Oncology Service and Lin Medical Center, Clalit Health Services, Haifa, Israel Complementary and Traditional Medicine Unit, Department of Family Medicine, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel Clalit Health Services, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author></analytic><series><title level="j">BMJ supportive & palliative care</title><idno type="eISSN">2045-4368</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents (adverse effects)</term><term>Breast Neoplasms (complications)</term><term>Breast Neoplasms (therapy)</term><term>Chemoradiotherapy, Adjuvant (adverse effects)</term><term>Clinical Trials as Topic</term><term>Dietary Supplements</term><term>Female</term><term>Humans</term><term>Physician-Patient Relations</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antinéoplasiques (effets indésirables)</term><term>Chimioradiothérapie adjuvante (effets indésirables)</term><term>Compléments alimentaires</term><term>Essais cliniques comme sujet</term><term>Femelle</term><term>Humains</term><term>Relations médecin-patient</term><term>Résultat thérapeutique</term><term>Tumeurs du sein ()</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antineoplastic Agents</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Chemoradiotherapy, Adjuvant</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antinéoplasiques</term><term>Chimioradiothérapie adjuvante</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Clinical Trials as Topic</term><term>Dietary Supplements</term><term>Female</term><term>Humans</term><term>Physician-Patient Relations</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Compléments alimentaires</term><term>Essais cliniques comme sujet</term><term>Femelle</term><term>Humains</term><term>Relations médecin-patient</term><term>Résultat thérapeutique</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Patients with breast cancer frequently turn to complementary medical therapies, including non-herbal nutritional supplements (NHNS). A number of NHNS products have been shown to potentially reduce the incidence and severity of adjuvant treatment-related symptoms. We review the literature and summarise the potential beneficial effects of these products and address issues regarding the safety of this practice. We offer an evidence-based approach for advancing a dialogue between doctors and patients interested in NHNS for adjuvant treatment-related toxicities. Taxane agents such as paclitaxel are frequently complicated by peripheral sensory neuropathy. The findings from several studies suggest that supplementation with vitamin E, glutamine and acetyl-L-carnithine may reduce the incidence and severity of paclitaxel-induced neuropathy. Glutamine has also been shown to reduce the incidence and severity of chemotherapy-induced and radiation-induced oral mucositis. Selenium can reduce upper limb lymphoedema following surgery and radiation treatments, and an antioxidant supplement has exhibited a protective effect against radiation-induced dermatitis. Finally, vitamin D has been shown to be effective in reducing the incidence and severity of arthralgia resulting from treatment with the aromatase inhibitor letrozole. The use of coenzyme Q10 was not found to be of benefit for cancer-related fatigue. There is a need to develop an open and non-judgmental dialogue between doctors and their patients with breast cancer, respecting the needs of the patient while addressing issues related to the efficacy and safety of NHNS products. Referral of patients to an integrative medicine consultant may help achieve these goals.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006436 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 006436 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:24644186
|texte= Non-herbal nutritional supplements for symptom relief in adjuvant breast cancer: creating a doctor-patient dialogue.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:24644186" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |